Stryker
(NYSE: SYK)
announced today that it completed its acquisition of pain management solution developer Vertos Medical.
Portage, Michigan–based Stryker said in August that it agreed to purchase the privately held company for an undisclosed amount. It marked the second acquisition announced by Stryker in August alone. The orthopedic giant continues to make M&A moves across multiple applications.
It shared plans to acquire AI-assisted virtual care company Care.ai on Aug. 12. The company completed that deal last month. Other deals made before the initial Vertos announcement in 2024 include the completed acquisitions of Molli Surgical, Artelon and SERF SAS.
Last month, Stryker continued its M&A push, buying new Foot & Ankle portfolio products from 4WEB Medical. Then, the company announced a deal to acquire neurotechnology company Nico Medical.
With the Vertos deal, Stryker is gaining a portfolio of interventional pain management solutions for chronic lower back pain caused by lumbar spinal stenosis. Vertos Medical’s minimally invasive surgical solution includes the Mild procedure, which involves going through a 5.1-mm incision to remove excess, thickened ligament tissue to restore space in the spinal canal and reduce the pressure on the spinal nerves. The procedure provides a solution for pain relief and may improve mobility without the need for major surgery.
“The acquisition of Vertos Medical enhances our unique, non-surgical solutions for interventionalists addressing chronic lower back pain, while broadening our presence in ambulatory surgery centers,” said Andy Pierce, group president, MedSurg and Neurotechnology, Stryker. “We look forward to enabling physicians with the minimally invasive mild procedure so patients can reclaim their quality of life.”
